Using recombinant human G-CSF to treat chemotherapy-induced neutropenia over 3 decades: What is next?
<p>Chemotherapy-Induced Neutropenia (CIN) is a potentially fatal side effect of cancer treatment, affecting > 50% of cancer patients treated with chemotherapy. Clinical use of recombinant human granulocyte colony-stimulating factor (rhG-CSF) has allowed for primary and secondary prophylaxis...
Saved in:
| Main Authors: | , , , , |
|---|---|
| Format: | Book |
| Published: |
Annals of Bone Marrow Research - Peertechz Publications,
2023-09-12.
|
| Subjects: | |
| Online Access: | Connect to this object online. |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|